H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.32 SGD Market Closed
Market Cap: 98.9m SGD

Relative Value

The Relative Value of one 1J5 stock under the Base Case scenario is hidden SGD. Compared to the current market price of 0.32 SGD, Hyphens Pharma International Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

1J5 Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
73
vs Industry
84
Median 3Y
0.5
Median 5Y
0.6
Industry
2.5
Forward
0.5
vs History
66
vs Industry
40
Median 3Y
9.7
Median 5Y
10.1
Industry
21.6
Forward
8.5
vs History
0
vs Industry
14
Median 3Y
15.1
Median 5Y
14.6
Industry
16.7
vs History
14
vs Industry
12
Median 3Y
11.5
Median 5Y
12.8
Industry
24
vs History
53
vs Industry
52
Median 3Y
1.4
Median 5Y
1.4
Industry
2.2
vs History
39
vs Industry
87
Median 3Y
0.4
Median 5Y
0.4
Industry
2.7
Forward
0.4
vs History
33
vs Industry
83
Median 3Y
1.1
Median 5Y
1.1
Industry
5.3
vs History
33
vs Industry
48
Median 3Y
4.1
Median 5Y
4.4
Industry
12.9
Forward
5.1
vs History
36
vs Industry
46
Median 3Y
5
Median 5Y
5.4
Industry
16.3
Forward
5.9
vs History
0
vs Industry
18
Median 3Y
11.6
Median 5Y
11.5
Industry
15.2
vs History
vs Industry
4
Median 3Y
6.6
Median 5Y
9.6
Industry
17.7
vs History
63
vs Industry
51
Median 3Y
1.3
Median 5Y
1.4
Industry
1.9

Multiples Across Competitors

1J5 Competitors Multiples
Hyphens Pharma International Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
Hyphens Pharma International Ltd
SGX:1J5
98.8m SGD 0.5 9.7 4.7 5.7
US
Eli Lilly and Co
NYSE:LLY
751.6B USD 15.3 67.7 36.3 39.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
377.4B USD 4.2 17.3 12.6 16.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.4 18.6 12.9 14.8
CH
Roche Holding AG
SIX:ROG
204.3B CHF 3.4 24.7 9.3 10.9
CH
Novartis AG
SIX:NOVN
188.7B CHF 4.4 18.4 10.8 14.5
UK
AstraZeneca PLC
LSE:AZN
162B GBP 4 28.2 130.7 197.2
US
Merck & Co Inc
NYSE:MRK
209.7B USD 3.3 12 8.9 10.8
IE
Endo International PLC
LSE:0Y5F
184.8B USD 79.7 -63.2 294 737.3
US
Pfizer Inc
NYSE:PFE
145.8B USD 2.3 18.5 7.8 11
P/E Multiple
Earnings Growth PEG
SG
H
Hyphens Pharma International Ltd
SGX:1J5
Average P/E: 23.9
9.7
6%
1.6
US
Eli Lilly and Co
NYSE:LLY
67.7
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.3
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.6
18%
1
CH
Roche Holding AG
SIX:ROG
24.7
32%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.2
36%
0.8
US
Merck & Co Inc
NYSE:MRK
12
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -63.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.5
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SG
H
Hyphens Pharma International Ltd
SGX:1J5
Average EV/EBITDA: 397.7
4.7
-4%
N/A
US
Eli Lilly and Co
NYSE:LLY
36.3
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.9
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.8
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.7
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.9
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
294
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SG
H
Hyphens Pharma International Ltd
SGX:1J5
Average EV/EBIT: 1 705.5
5.7
2%
2.9
US
Eli Lilly and Co
NYSE:LLY
39.7
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.6
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.8
14%
1.1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14.5
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.2
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.8
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
11
10%
1.1